Repligen (United States)

Recent papers from Repligen (United States)

1. Clinical utility of real-time comprehensive molecular testing in large B-cell lymphomaBlood Advances · 2026
2. Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical ImplicationsClinical Cancer Research · 2026
3. Association of angiogenic, fibrotic, and immunosuppressive tumor microenvironment with immunotherapy outcomes in metabolic disease–associated biliary tract cancers.Journal of Clinical Oncology · 2026
4. IvoLoC: A phase II trial of ivonescimab (IVO) in endocrine-refractory hormone receptor (HR)–positive or triple-negative (TN) metastatic invasive lobular carcinoma (mILC).Journal of Clinical Oncology · 2026
5. Real-world clinical utility of comprehensive genomic and transcriptomic profiling in metastatic breast cancer (mBC).Journal of Clinical Oncology · 2026
6. Effects of a multimodal TCR/BCR repertoire foundation model on blood RNA-seq–based prediction of severe adverse event risk and rheumatoid arthritis.Journal of Clinical Oncology · 2026
7. Immune priming with the EZH2 inhibitor tazemetostat in B-cell lymphomas receiving CAR T-cell therapy.Journal of Clinical Oncology · 2026
8. Examining the tumor microbiology and microenvironment of patients with triple-negative inflammatory breast cancer receiving KEYNOTE-522.Journal of Clinical Oncology · 2026
9. Developing harmonized tumor microenvironment subtypes for patient stratification in clinical trials.Journal of Clinical Oncology · 2026
10. Multimodal immunoprofiling of peripheral blood using foundation models of the immune system for predicting immunotherapy response and toxicity in the RADIOHEAD pan-cancer cohort.Journal of Clinical Oncology · 2026
11. Abstract 5421: Determining the benefit of comprehensive molecular testing in advanced cancers: BostonGene and Exigent Genomic INsight (BEGIN) study.Cancer Research · 2026
12. Abstract 114: Unraveling tumor- and tissue-specific gene expression patterns from plasma-derived cfRNA.Cancer Research · 2026
13. Abstract 1451: Visualizing the genotype-phenotype link: Predicting drug-induced tissue dynamics with RNA-based diffusion models.Cancer Research · 2026
14. Abstract 3877: Integrative application of Lymphly reveals shared molecular landscape across B-cell lymphomas.Cancer Research · 2026
15. Abstract 7935: Multimodal immunotherapy remodels the tumor microenvironment in hepatocellular carcinoma: Integrative spatial and transcriptomic profiling from a Phase II trialCancer Research · 2026
16. Abstract 4164: Implementation of a diffusion-based color checker for histological image batch correctionCancer Research · 2026
17. Abstract 452: Therapeutic potential of AURKA inhibition in ER+ inflammatory breast cancer.Cancer Research · 2026
18. Abstract 2437: A comparative scoring framework for BCMA-, GPRC5D- and CD38-targeted therapies in multiple myelomaCancer Research · 2026
19. Abstract 1468: Germline whole exome sequencing implicates homologous recombination repair pathway genes as risk factors in SMARCB1 deficient renal medullary phenotypes without sickle hemoglobinopathies.Cancer Research · 2026
20. Abstract 3763: CCR7 expression and spatial distribution in inflammatory breast cancer: A baseline characterization for therapeutic targetingCancer Research · 2026